Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novamind Inc (OP: NVMDF ) N/A UNCHANGED Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novamind Inc < Previous 1 2 3 Next > Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies December 16, 2021 Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000 December 08, 2021 The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics... Via Benzinga Topics Death Exposures Death Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program December 06, 2021 Novamind Inc. (OTCQB:NVMDF),... Via Benzinga Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders December 06, 2021 Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the... From Novamind Inc. Via AccessWire Topics Death Exposures COVID-19 Death Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders December 02, 2021 Novamind Inc. (OTCQB:NVMDF) a mental health compan... Via Benzinga Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6 December 02, 2021 TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... From Novamind Inc. Via AccessWire Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network December 01, 2021 Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic model TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc.... From Novamind Inc. Via AccessWire Novamind Reports Fiscal Q1 Financial Results and Operating Highlights November 29, 2021 - Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice - Total revenue of $1,857,750, +113% when compared to same period last year - Total working capital of... From Novamind Inc. Via AccessWire Novamind Unveils New Logo and Invests in Unified Brand November 24, 2021 TORONTO, ON / ACCESSWIRE / November 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc Via AccessWire Psychedelic Medicine: Major Health Providers Including Blue Cross Now Cover Ketamine Treatments November 18, 2021 Four major health insurance providers recently approved psychedelic medicine company Novamind Inc. (CSE: Via Benzinga Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona November 16, 2021 TORONTO, ON / ACCESSWIRE / November 16, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness November 15, 2021 TORONTO, ON / ACCESSWIRE / November 15, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... From Novamind Ventures Inc. Via AccessWire Novamind Enters New Lease Agreement Responding to Patient Demand November 12, 2021 TORONTO, ON / ACCESSWIRE / November 12, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced... From Novamind Inc. Via AccessWire Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others November 11, 2021 Compass Pathways reported Via Talk Markets Novamind Secures Insurance Coverage for Ketamine from Four Major Payors November 10, 2021 Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind TORONTO, ON / ACCESSWIRE / November 10, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... From Novamind Inc. Via AccessWire Exposures Product Safety Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading November 08, 2021 TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces... From Novamind Inc. Via AccessWire Novamind Reports FY2021 Financial Results and Operating Highlights November 05, 2021 - Industry-leading revenue, $6,069,247 in FY2021 - Total working capital of $9,680,431 to fund operations - Expanded network to six clinics and three clinical research sites - Contracted for eight... From Novamind Inc. Via AccessWire Exposures COVID-19 Compass Pathways 2.0: A New Rally In Psychedelic Stocks? November 04, 2021 Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? Via Talk Markets Topics Initial Public Offering Exposures Securities Market Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements November 04, 2021 TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? October 23, 2021 The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. Via Talk Markets Novamind Unveils Stealth Mode Investment in Alto Neuroscience October 22, 2021 TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased... From Novamind Ventures Inc. Via AccessWire Novamind Granted DEA Licenses for Psilocybin Research October 13, 2021 Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances TORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... From Novamind Inc. Via AccessWire Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program October 11, 2021 The Week In Psychedelics Via Benzinga Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga Novamind to Present at LD Micro and KCSA Conferences October 08, 2021 TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga Psychedelic Medicine For End-Of-Life And Palliative Care Patients: Novamind Launches Treatment Program October 07, 2021 Novamind (Canadian: NM) (OTCQB:NVMDF), a company in the ps... Via Benzinga Novamind Launches New Psychedelic Palliative Care Program October 07, 2021 Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illness TORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc.... From Novamind Inc. Via AccessWire Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction October 04, 2021 The Week In Psychedelics: Via Benzinga Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021 October 04, 2021 Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapy TORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"... From Novamind Ventures Inc. Via AccessWire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.